Showing results (31-40 of 521) with videos related to

Sort By:
Pageof 53
Journal of the American Chemical Society|June 16, 2010
Coexistence of an ILPR i-motif and a partially folded structure with comparable mechanical stability revealed at the single-molecule levelSoma Dhakal, Joseph D Schonhoft, Deepak Koirala, et al.
Biochemistry|August 19, 2015
G-Quadruplex-Enabling Sequence within the Human Tyrosine Hydroxylase Promoter Differentially Regulates TranscriptionMohamed M Farhath, Matthew Thompson, Sujay Ray, et al.
Nucleic Acids Research|March 28, 2009
Direct experimental evidence for quadruplex-quadruplex interaction within the human ILPRJoseph D Schonhoft, Rabindra Bajracharya, Soma Dhakal, et al.
Journal of Inorganic Biochemistry|August 28, 2016
Kinetic studies on the reaction of cob(II)alamin with hypochlorous acid: Evidence for one electron oxidation of the metal center and corrin ring destructionRohan S Dassanayake, Mohamed M Farhath, Jacob T Shelley, et al.
Cancer Treatment and Research Communications|September 26, 2022
Deep sequencing reveals the spectrum of BCR-ABL1 mutations upon front-line therapy resistance in chronic myeloid leukemia: An Eastern-Indian cohort studySamya Dey, Soumi Basu, Shahena Shah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2021
Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoterNathan Beals, Mohamed M Farhath, Prakash Kharel, et al.
Journal of the American Chemical Society|January 22, 2009
ILPR G-quadruplexes formed in seconds demonstrate high mechanical stabilitiesZhongbo Yu, Joseph D Schonhoft, Soma Dhakal, et al.
Biopolymers|August 19, 2009
ILPR repeats adopt diverse G-quadruplex conformations that determine insulin bindingJoseph D Schonhoft, Arijit Das, Firehiwot Achamyeleh, et al.
ACS Omega|July 20, 2018
Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer CellsNathan Beals, Praveena S Thiagarajan, Eric Soehnlen, et al.
NAR Molecular Medicine|February 5, 2025
Combining CRISPR activation and interference capabilities using dCas9 and G-quadruplex structuresMohammad Lutful Kabir, Sineth G Kodikara, Mohammed Enamul Hoque, et al.
Pageof 53